BridgeMD
New treatment option for Cardiovascular Diseases
Official title The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
ClinicalTrials.gov ID: NCT06476795
What this study is testing
- What it's testing
- Recently a dietary recommendation of 400 - 600 mg/ day has been proposed for the reduced risk of developing cardiovascular disease. Dietary flavanols can be obtained from the intake of foods such as tea, cocoa, wine, berries and apples.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 70, women only. Healthy volunteers may be eligible.
You may be able to join if
- Postmenopausal female, with a cessation of menses for at least 2 years
- 45-70 years of age
- BMI 25- 49.9 kg/m2
- Fasting triglycerides \> 120 mg/dL
- Subject is willing and able to comply with the study protocols and procedures.
You likely can't join if
- Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
- Prescription medications and supplements, except for a 6 month stable dose of thyroid medications
- Vegan, Vegetarians, food faddists or those consuming a non-traditional diet
- Fruit consumption ≥ 3 cups/day
- Vegetable consumption ≥ 4 cups/day
- Coffee/tea ≥ 3 cups/day
See the full eligibility criteria
- Postmenopausal female, with a cessation of menses for at least 2 years
- 45-70 years of age
- BMI 25- 49.9 kg/m2
- Fasting triglycerides \> 120 mg/dL
- Subject is willing and able to comply with the study protocols and procedures.
- Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
- Prescription medications and supplements, except for a 6 month stable dose of thyroid medications
- Vegan, Vegetarians, food faddists or those consuming a non-traditional diet
- Fruit consumption ≥ 3 cups/day
- Vegetable consumption ≥ 4 cups/day
- Coffee/tea ≥ 3 cups/day
- Dark chocolate ≥ 3 oz/day
- Self-reported restriction of physical activity due to a chronic health condition
- Self-reported chronic/routine high intensity exercise
- Blood pressure ≥ 140/90 mm Hg
- Self-reported renal or liver disease
- Self-reported heart disease, which includes cardiovascular events and stroke, diabetes
- Peripheral artery disease Raynaud's syndrome or disease
- Inability to properly place or wear the PAT probes or abnormal measurements on pre-screening PAT
- Self-reported cancer within past 5 years
- Self-reported gastrointestinal disorders, apart from appendix removal
- Unwillingness to stop any supplement use, including herbal, plant or botanical, fish oil, oil supplements six weeks prior to study enrollment.
- Indications of substance or alcohol abuse within the last 3 years
- All forms of smoking (e.g. vaping, cigarette, cannabis)
- Current enrollee in a clinical research study.
The study team makes the final eligibility decision.
Where it's taking place
- Davis, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Davis, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.